A pilot dose finding study of pioglitazone in autistic children

BACKGROUND: Pioglitazone is a promising compound for treatment of core autism spectrum disorder (ASD) symptoms as it targets multiple relevant pathways, including immune system alterations. OBJECTIVE: This pilot study aimed to elucidate the maximum tolerated dose, safety, preliminary evidence of eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Capano, Lucia, Dupuis, Annie, Brian, Jessica, Mankad, Deepali, Genore, Lisa, Hastie Adams, Rianne, Smile, Sharon, Lui, Toni, Odrobina, Dina, Foster, Jane A., Anagnostou, Evdokia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258310/
https://www.ncbi.nlm.nih.gov/pubmed/30498564
http://dx.doi.org/10.1186/s13229-018-0241-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258310/
https://www.ncbi.nlm.nih.gov/pubmed/30498564
http://dx.doi.org/10.1186/s13229-018-0241-5

Ejemplares similares